PsyQ: Journal Club

This is an AI generated podcast. Stay updated on the foundational research shaping our field. Psych Bytes provides concise, expert-reviewed summaries of landmark papers for busy psychiatry residents and clinicians. We leverage AI tools like NotebookLM to kickstart the summary process, followed by human review and contextualization to ensure accuracy and clinical relevance. Your quick guide to essential psychiatric literature. These are merely summaries meant to improve access through convenience, please be mindful that inaccuracies may be present - please refer to original source material for the most accurate and representative information. upathak.substack.com

PsyQ: Journal Club is a science podcast hosted by Unknown Host, with 41 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.

Unknown Host hosts PsyQ: Journal Club, a science show with 41 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  Episode #41

  Dementia in Severe Schizophrenia - PsyQ Episode 41

  Apr 19, 202620 minS1

  <p>In this episode of PsyQ, we critically examine the etiology of cognitive decline in severe, extremely treatment-resistant schizophrenia (SETRS) through the lens of a 2026 JAMA Psychiatry cohort study. By analyzing clinical and genetic data from 155 chronically institutionalized patients, the research demonstrates that the cognitive deficit profile in SETRS intensifies the patterns seen in community-dwelling schizophrenia rather than mimicking Alzheimer disease (AD) or frontotemporal dementia (FTD). Genomic sequencing revealed no pathogenic variants in Mendelian dementia genes and a significantly lower APOE4 allele frequency compared to AD and Lewy body dementia. Crucially, the profound cognitive impairment observed was not attributable to...

  ListenShow Notes
• 

  Episode #40

  Metabolic Psychiatry: Ketosis for TRD - PsyQ Episode 40

  Mar 23, 202615 minS1

  <p>In this episode of PsyQ, we critically evaluate the recent randomized clinical trial by Gao et al. published in JAMA Psychiatry investigating the ketogenic diet (KD) as an adjunctive treatment for treatment-resistant depression (TRD). The study randomized 88 adults with TRD to either a 6-week, highly supported KD or an active phytochemical control diet, specifically isolating the dietary variable by strictly controlling for weight loss. While both cohorts demonstrated rapid symptom reduction, the KD group showed a modest, statistically significant advantage in PHQ-9 scores at 6 weeks compared to the control (-2.18 points). We break down the clinical utility of these...

  ListenShow Notes
• 

  Episode #39

  Brain and Blood Biomarkers in MDD - PsyQ Episode 39

  Mar 1, 202613 minS1

  <p></p> <br/><br/>This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit upathak.substack.com

  ListenShow Notes
• 

  Episode #38

  In-Utero Antipsychotic Medication Exposure - PsyQ Episode 38

  Feb 15, 202615 minS1

  <p></p> <br/><br/>This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit upathak.substack.com

  ListenShow Notes
• 

  Episode #37

  The Psychic Tourniquet: Ultra-Low-Dose Buprenorphine for Acute Suicidality - PsyQ Episode 37

  Feb 7, 202617 minS1

  <p>In this episode of PsyQ, we confront the "zone of danger" in acute suicidality—the critical lag period where standard antidepressants often fail to address immediate "psychache". Anchored by the seminal Yovell et al. (2016) randomized controlled trial, we explore the neurobiological overlap between physical and social pain , testing the hypothesis that ultra-low-dose buprenorphine (starting at 0.1 mg) can modulate the endogenous opioid system to treat separation distress directly. We dissect the study's groundbreaking findings—including a significant reduction in suicidal ideation distinct from depression improvement and robust efficacy in patients with Borderline Personality Disorder —while rigorously outlining the safety parameters, zero-w...

  ListenShow Notes

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.